Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun-Peng Liu

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Chinese Journal of Cancer|December 24, 2017
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trialRui-Hua Xu, Lin Shen, Ke-Ming Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Journal of Cancer Research and Clinical Oncology|June 14, 2023
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS studyQing Zhou, He-Long Zhang, Li-Yan Jiang, et al.
Translational Lung Cancer Research|July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Chinese Journal of Cancer|December 24, 2017
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trialRui-Hua Xu, Lin Shen, Ke-Ming Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Journal of Cancer Research and Clinical Oncology|June 14, 2023
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS studyQing Zhou, He-Long Zhang, Li-Yan Jiang, et al.
Translational Lung Cancer Research|July 28, 2018
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panelYi-Long Wu, Chang-Li Wang, Mei-Lin Liao, et al.
Pageof 13